Impaired Fasting Glucose (IFG) Completed Phase 4 Trials for Nateglinide (DB00731)

Also known as: Impaired Fasting Glucose / [D]Impaired fasting glucose / Elevated fasting glucose

IndicationStatusPhase
DBCOND0042125 (Impaired Fasting Glucose (IFG))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00259168Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?Prevention